TuHURA Biosciences Inc (HURA)

Currency in USD
3.1100
-0.0400(-1.27%)
Real-time Data·
HURA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.04243.4100
52 wk Range
0.41004.4400
Key Statistics
Prev. Close
3.15
Open
3.22
Day's Range
3.0424-3.41
52 wk Range
0.41-4.44
Volume
1.4M
Average Vol. (3m)
1.87M
1-Year Change
-24.2387%
Book Value / Share
0.34
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HURA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.2500
Upside
+165.27%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

TuHURA Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company’s lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-functional and bi-specific antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.

Compare HURA to Peers and Sector

Metrics to compare
HURA
Peers
Sector
Relationship
P/E Ratio
−6.7x−4.3x−0.5x
PEG Ratio
−0.14−0.090.00
Price / Book
9.8x5.2x2.6x
Price / LTM Sales
-10.3x3.2x
Upside (Analyst Target)
154.0%93.5%47.6%
Fair Value Upside
Unlock2.1%6.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.2500
(+165.27% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Rodman & Renshaw
Buy7.00+128.01%-New CoverageApr 15, 2026
H.C. Wainwright
Buy10.00+225.73%12.00MaintainJan 09, 2026
H.C. Wainwright
Buy12.00+290.88%-MaintainAug 22, 2025
H.C. Wainwright
Buy12.00+290.88%-MaintainJun 30, 2025
Brookline Capital Markets
Buy9.00+193.16%-New CoverageJun 23, 2025

Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
-0.13 / -0.15
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

HURA Income Statement

People Also Watch

0.746
USEG
+2.73%
11.2450
LWLG
-7.98%
0.708
EONR
+1.51%
14.3199
TENX
-3.11%
7.48
IBRX
-1.64%

FAQ

What Is the TuHURA Biosciences (HURA) Stock Price Today?

The TuHURA Biosciences stock price today is 3.1100 USD.

What Stock Exchange Does TuHURA Biosciences Trade On?

TuHURA Biosciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for TuHURA Biosciences?

The stock symbol for TuHURA Biosciences is "HURA."

What Is the TuHURA Biosciences Market Cap?

As of today, TuHURA Biosciences market cap is 195.1900M USD.

What Is TuHURA Biosciences's Earnings Per Share (TTM)?

The TuHURA Biosciences EPS (TTM) is -0.6272.

From a Technical Analysis Perspective, Is HURA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has TuHURA Biosciences Stock Split?

TuHURA Biosciences has split 5 times.

How Many Employees Does TuHURA Biosciences Have?

TuHURA Biosciences has 22 employees.

What is the current trading status of TuHURA Biosciences (HURA)?

As of Apr 15, 2026, TuHURA Biosciences (HURA) is trading at a price of 3.1100 USD, with a previous close of 3.1500 USD. The stock has fluctuated within a day range of 3.0424 USD to 3.4100 USD, while its 52-week range spans from 0.4100 USD to 4.4400 USD.

What Is TuHURA Biosciences (HURA) Price Target According to Analysts?

The average 12-month price target for TuHURA Biosciences is 8.2500 USD, with a high estimate of 10 USD and a low estimate of 7 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +165.27% Upside potential.

What Is the HURA Premarket Price?

HURA's last pre-market stock price is 3.1540 USD. The pre-market share volume is 17,610.0000, and the stock has decreased by 0.0040, or 0.1300%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.